β -Glucans and their Applications in Cancer Therapy: Focus on human studies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
709-719
Author(s):
Eiman Aleem
NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
777-790
Author(s):
Yasrib Qurishi, Abid Hamid, Parduman R. Sharma, Zahoor A. Wani, Dilip M. Mondhe, Shashank K. Singh, Mohmmad A. Zargar, Samar S. Andotra, Bhahwal A. Shah, Subhash C. Taneja and Ajit K. Saxena
Inhibitors of the Immunoproteasome: Current Status and Future Directions
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
4140-4151
Author(s):
Zachary Miller, Lin Ao, Kyung Bo Kim and Wooin Lee
Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
4053-4093
Author(s):
Wendy Xolalpa, Patricia Perez-Galan, Manuel S. Rodríguez and Gael Roue
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
4025-4038
Author(s):
Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou
VEGF in Tumor Progression and Targeted Therapy
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
423-443
Author(s):
Vladimir P. Chekhonin, Sergey A. Shein, Anna A. Korchagina and Olga I. Gurina
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
2712-2722
Author(s):
R. Voltan, P. Secchiero, B. Ruozi, L. Caruso, F. Forni, M. Palomba, G. Zauli and M.A. Vandelli
Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
Journal:
Current Topics in Medicinal Chemistry
Volume:
13
Page:
1069-1097
Author(s):
Antonio Carrieri, Violeta I. Perez- Nueno, Giovanni Lentini and David W. Ritchie
MicroRNAs and Cancer: Towards a Personalized Medicine
Journal:
Current Molecular Medicine
Volume:
13
Page:
751-756
Author(s):
M. Fabbri
Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
762-767
Author(s):
Monika Kusio- Kobialka, Wioleta Dudka- Ruszkowska, Massimo Ghizzoni, Frank J. Dekker and Katarzyna Piwocka